19/03/2026
Meningitis Vaccination – Important Information
Following recent reports of a meningitis (MenB) outbreak, we would like to provide some clarification and reassurance regarding current vaccination guidance.
Routine Vaccinations and Meningitis Protection:
Many routine childhood vaccinations offer protection against forms of meningitis. These include:
• MenB
• DTaP/IPV/Hib/HepB
• PCV
• MMRV
• MenACWY
Current Outbreak Information:
The recent outbreak relates specifically to MenB.
The MenACWY vaccine does not protect against MenB and is therefore not being offered in direct response to this outbreak.
Keep an Eye Out for Symptoms:
Although meningitis is uncommon and does not spread easily, symptoms can develop quickly. Not everyone will have all symptoms, and they can appear in any order. Symptoms can worsen rapidly, so keep checking on anyone who is unwell. Do not wait for a rash.
Early Symptoms (can look like flu):
• Fever, vomiting, headache, muscle or joint pain, cold hands and feet, feeling unusually tired or unwell
Later symptoms of meningitis
• Severe sleepiness/difficulty waking, stiff neck, severe headache, vomiting, sensitivity to light, confusion/delirium, seizures (fits).
Symptoms of Septicaemia (sepsis)
• Fever with shivering, severe pain in muscles/joints/limbs, very cold hands/feet, pale/blotchy/mottled skin, rapid breathing, stomach cramps/diarrhoea, red or purple rash that doesn’t fade with pressure (glass test), difficulty walking/standing, severe sleepiness or loss of consciousness.
MenACWY Eligibility:
You may still be eligible for the MenACWY vaccine if:
• You are under 25 and missed the school vaccination programme
• You are preparing to start university
• You are in a clinical risk group
• You require the vaccine for travel
If you believe you may be eligible, please contact the practice and we can check this for you.
MenB Vaccine Availability:
The MenB vaccine is routinely offered to babies at 8 weeks, 12 weeks and 1 year of age. It is not routinely available for older children or adults unless advised by national guidance.
We continue to follow recommendations from the UK Health Security Agency and will update patients if guidance changes.
Thank you for your understanding and cooperation.
